MedPath

Effects of Modified Otago Exercises in Individuals with Diabetic Neuropathy

Not Applicable
Completed
Conditions
Neuropathy
Diabetes Mellitus, Type 2
Interventions
Other: Control Group
Other: Exercise Group
Registration Number
NCT05691738
Lead Sponsor
Karamanoğlu Mehmetbey University
Brief Summary

The aim of the study is to investigate the effects of modified otago exercises on joint position sense, balance and physical fitness parameters in individuals with diabetic neuropathy. In addition aim of to examine the effects of exercise on metabolic variables and to gain exercise awareness in diabetic individuals.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
38
Inclusion Criteria
  • Individuals with Neuropathy Diagnosed with Type 2 Diabetes between the Ages of 40-65 Years
  • Cooperative, able to take instructions (Mini Mental Test score of 24 and above)
  • Able to walk independently
  • With a Body Mass Index Below 40 Kg/M2
  • Not Doing Regular Physical Activity for the Last 6 Months
  • Voluntarily participated in the research
Exclusion Criteria
  • Additional neurological problem other than neuropathy
  • Any orthopedic or systemic problems that will prevent him from performing the exercises
  • The presence of pathology related to the lower limb that occurred within the last 6 months (surgery, fracture, soft tissue injuries, etc.)
  • Pregnant
  • Vision problem that cannot be corrected with glasses or lenses
  • Hearing loss that cannot be corrected with hearing aids
  • Foot ulcer
  • Patients who have been diagnosed with cancer and are receiving chemotherapy in this context
  • With limitation of the range of motion of the joints of the lower extremities

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control GroupControl GroupInformation will be given about diabetes and its complications.Participants will be given a home program
Exercise GroupExercise GroupInformation will be given about diabetes and its complications.Modified Otago Exercise will be applied by the physiotherapist.Participants will be given a home program
Primary Outcome Measures
NameTimeMethod
Joint Position Sense EvaluationChange from baseline at 8 weeks

Ankle joint position sense of 10 degrees dorsiflexion and 15 degrees plantar flexion target angles will be evaluated.

Blood HDL Cholesterol LevelChange from baseline at 8 weeks

Routinely, the HDL cholesterol (mg/dL) level will be recorded in the blood laboratory results by the endocrinologist.

Blood LDL Cholesterol LevelChange from baseline at 8 weeks

Routinely, the LDL cholesterol (mg/dL) level will be recorded in the blood laboratory results by the endocrinologist.

Blood Glucose LevelChange from baseline at 8 weeks

Routinely, the glycated hemoglobin (Hba1c) (mg/dL) level will be recorded in the blood laboratory results by the endocrinologist.

Blood Cholesterol LevelChange from baseline at 8 weeks

Routinely, the cholesterol (mg/dL) level will be recorded in the blood laboratory results by the endocrinologist.

Blood Triglycerides LevelChange from baseline at 8 weeks

Routinely, the triglycerides (mg/dL) level will be recorded in the blood laboratory results by the endocrinologist.

The Timed Up & Go (Functional Mobility Assessment)Change from baseline at 8 weeks

Patients sitting in a chair without armrests will be asked to stand up with the start command and walk the 3-meter distance, whose start and end points are specified before, turn around and sit on the chair again. The test will be repeated 3 times and the average time will be recorded.

Lean Body WeightChange from baseline at 8 weeks

Calculated in kilograms (kg) by subtracting body fat from body weight.

Cardio-respiratory Fitness EvaluationChange from baseline at 8 weeks

A distance of 30 meters is created in an area measuring 10x40 meters, the start and end points are marked.Patients are asked to walk on the designated line for 6 minutes at the highest speed they can walk without running.At the end of 6 minutes, the distance they have walked is recorded in meters.

Balance EvaluationChange from baseline at 8 weeks

Balance Error Scoring System:Practices are performed on hard and soft ground separately in 3 positions, two feet, one foot and tandem stance, with eyes closed.After the test position is taught to the patient, the patient is asked to close their eyes and hold the position for 20 seconds.A mistake made for 20 seconds on each floor and position is recorded as 1 point.The maximum error score is 10.All assessments are made without shoes

Body Mass İndex EvaluationChange from baseline at 8 weeks

Body weight of the individual is recorded in kilograms and height in meters.Calculated by dividing body weight by the square of the height in meters (kg/m2)

Body Fat PercentageChange from baseline at 8 weeks

Body fat percentage is calculated as percentage (%) with Tanita BC730 brand scale

Body WeightChange from baseline at 8 weeks

Calculated in kilograms (kg) with a Tanita BC730 brand scale

Sit and Reach Test (Flexibility ) EvaluationChange from baseline at 8 weeks

The patient is asked to lie down without bending his knees towards the ruler placed on the flexibility table. Before the test, the patient is asked to reach forward 1-2 times and is taught what to do. Then the patient is asked to lie forward 3 times and the average of the data obtained is recorded in centimeters.

Muscle Strength (30-second Chair Stand Test) EvaluationChange from baseline at 8 weeks

Sitting in a standard chair without armrests, the patient is asked to cross his hands over his shoulder. With the start command, the stopwatch is kept and the patient is asked to stand up completely from the chair and sit down again. The number of repetitive movements for 30 seconds is recorded.

Falling RiskChange from baseline at 8 weeks

Fall Efficacy Scale International: It is a common test battery with 16 items that reveals the possibility of falling in patients.The higher the test score, the higher the probability of falling in the patient.

Secondary Outcome Measures
NameTimeMethod
Neuropathic Pain ScaleChange from baseline at 8 weeks

Self-Leeds Assesment of Neuropathic Symptoms \& Signs Pain Score: It is a simple test used in the differential diagnosis of neuropathic pain at the bedside.A score of 12 and above is diagnostic for neuropathic pain

Diaposan (Vibration) Evaluationa day before the start of treatment

A 128 Hz tuning fork, which was oscillated before, is placed on the metatarsophalangeal joint of both feet of the individual and the patient is asked to feel the vibration. If the investigator still perceives the vibration as soon as the patient says he does not feel the vibration, it is considered neuropathy.

Cognitive Statusa day before the start of treatment

Mini Mental Test will be used to evaluate the cognitive status of individuals. It is a short, useful, standardized test that provides the opportunity to evaluate cognitive performance in a short time. A high score indicates a good cognitive status. The maximum possible score is 30. A score of 17 and below is considered severe dementia, a score of 18-23 is considered mild dementia, and a score of 24-30 is considered normal.

Monofilament Evaluationa day before the start of treatment

The monofilament is touched to the relevant point on the foot until it takes a C shape. Absence of a 4.17 or thicker monofilament is interpreted as being compatible with neuropathy.Failure to detect a 5.07 monofilament is considered as a loss of protective sensation.

Individual Exercise İntensitya day before the start of treatment

Borg Scale: It is a method used to determine the exercise tolerance of the individual.The individual scores the fatigue she feels between 6-20.Fatigue level; nothing (6), very very light (7-8), very light (9-10), light (11-12), somewhat difficult (13-14), difficult (15-16), very difficult (17- 18), very very difficult (19), exhaustion (20)

Trial Locations

Locations (1)

Karaman Provincial Health Directorate Karaman Training and Research Hospital

🇹🇷

Karaman, Center, Turkey

© Copyright 2025. All Rights Reserved by MedPath